Inhalation Sciences evaluating final data in profitable EU antibiotic resistance project FORMAMP
EU authorities have approved and released a final payment of 2 MSEK to ISAB for its four-year work on the FORMAMP project. The project has been profitable scientifically and commercially for ISAB, bringing in a total of over 5 MSEK over its duration and providing strong scienctific proof-points in favour of PreciseInhale. These will be published in the coming 6-12 months.In the future could TB patients inhale nanostructure formulations of anti-bacterial peptides to treat the disease? Over the last four years 16 EU research bodies have been exploring such possibilities in a project on new